Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trial

Journal:

The Lancet Oncology

Published:

2025-11-26

DOI:

10.1016/s1470-2045(25)00523-6

Affiliations:

43

Authors:

45

Go to article

Institutions	Authors	Share
Hengrui, China	3.000000	0.07
Beijing Cancer Hospital / School of Oncology, PKUHSC, China	2.000000	0.04
Second Affiliated Hospital, AHMU, China	2.000000	0.04
Guangdong-Hong Kong Joint Laboratory for RNA Medicine, China	1.500000	0.03
Zhejiang Cancer Hospital (ZJCH), China	1.000000	0.02
The First Affiliated Hospital of Henan University of Science and Technology, China	1.000000	0.02
The First Hospital of China Medical University, China	1.000000	0.02
Liaoning Cancer Hospital and Institute, China	1.000000	0.02
Guizhou Provincial People's Hospital, China	1.000000	0.02
Guangdong Academy of Medical Sciences (Guangdong Provincial People’s Hospital), China	1.000000	0.02
Southwest Hospital, Army Medical University, China	1.000000	0.02
Fudan University Shanghai Cancer Center (FUSCC), China	1.000000	0.02
The First Affiliated Hospital of Chongqing Medical University, China	1.000000	0.02
Nanfang Hospital, China	1.000000	0.02
Shandong Cancer Hospital, China	1.000000	0.02
Cancer Hospital of Yunnan Province, China	1.000000	0.02
Renji Hospital, SJTU, China	1.000000	0.02
Tangdu Hospital, China	1.000000	0.02
Wuhan Union Hospital, HUST, China	1.000000	0.02
Hubei Cancer Hospital (HBCH), China	1.000000	0.02
The Affiliated Hospital, Jiangnan University, China	1.000000	0.02
Sichuan Cancer Hospital, China	1.000000	0.02
Hospital and Cancer Center, CQU, China	1.000000	0.02
Henan Cancer Hospital, ZZU, China	1.000000	0.02
Zhongshan Hospital, Fudan University, China	1.000000	0.02
Peking University Third Hospital (PUTH), PKUHSC, China	1.000000	0.02
Xuzhou Central Hospital (XZCH), China	1.000000	0.02
Xijing Hospital, China	1.000000	0.02
Jiangxi Provincial Cancer Hospital, China	1.000000	0.02
Jiangsu Cancer Hospital, China	1.000000	0.02
Shanxi Bethune Hospital, China	1.000000	0.02
Harbin Medical University Cancer Hospital, China	1.000000	0.02
Yuncheng Central Hospital, China	1.000000	0.02
Sun Yat-sen University Cancer Center (SYSUCC), SYSU, China	1.000000	0.02
Jiangsu Provincial People's Hospital (The First Affiliated Hospital of Nanjing Medical University), China	1.000000	0.02
Tongji Hospital (TJH), HUST, China	1.000000	0.02
Hunan Cancer Hospital, China	1.000000	0.02
Tumor Hospital of Guangxi Medical University, China	1.000000	0.02
Tianjin Medical University Cancer Institute and Hospital, TMU, China	1.000000	0.02
Nanchang People’s Hospital, China	1.000000	0.02
Zenith Institute of Medical Sciences, China	0.500000	0.01

Interested in Oncology and Carcinogenesis?